The role of particle therapy in the treatment of locally recurrent rectal cancer: a systematic review
By: Ana Perpar, Petra Georg and Ajra Secerov Ermenc
References
- Cancer Factsheets in EU-27 countries - 2020 | ECIS - European Cancer Information System [Internet]. [cited 2023 Nov 12]. Available at: https://ecis.jrc.ec.europa.eu/cancer-factsheets-eu-27-countries-2020
- Heald RJ, Ryall RDH. Recurrence and survival after total mesorectal excision for rectal cancer. Lancet 1986; 327: 1479-82. doi: 10.1016/S0140-6736(86)91510-2
- Sauer R, Liersch T, Merkel S, Fietkau R, Hohenberger W, Hess C, et al. Preoperative Versus postoperative chemoradiotherapy for locally advanced rectal cancer: results of the German CAO/ARO/AIO-94 Randomized Phase III Trial after a median follow-up of 11 years. J Clin Oncol 2012; 30: 1926-33. doi: 10.1200/JCO.2011.40.1836
- Folkesson J, Birgisson H, Pahlman L, Cedermark B, Glimelius B, Gunnarsson U. Swedish Rectal Cancer Trial: long lasting benefits from radiotherapy on survival and local recurrence rate. J Clin Oncol 2005; 23: 5644-50. doi: 10.1200/JCO.2005.08.144
- Conroy T, Castan F, Etienne PL, Rio E, Mesgouez-Nebout N, Evesque L, et al. Total neoadjuvant therapy with mFOLFIRINOX versus preoperative chemoradiotherapy in patients with locally advanced rectal cancer: long-term results of the UNICANCER-PRODIGE 23 Trial. Ann Oncol 2024; 35: 873-81. doi: 10.1016/j.annonc.2024.06.019
- Fokas E, Schlenska-Lange A, Polat B, Klautke G, Grabenbauer GG, Fietkau R, et al. Chemoradiotherapy plus induction or consolidation chemotherapy as total neoadjuvant therapy for patients with locally advanced rectal cancer: long-term results of the CAO/ARO/AIO-12 Randomized Clinical Trial. JAMA Oncol 2022; 8: e215445. doi: 10.1001/jamaoncol.2021.5445
- Ciseł B, Pietrzak L, Michalski W, Wyrwicz L, Rutkowski A, Kosakowska E, et al. Long-course preoperative chemoradiation versus 5 × 5 Gy and consolidation chemotherapy for clinical T4 and fixed clinical T3 rectal cancer: long-term results of the randomized Polish II study. Ann Oncol 2019; 30: 1298-303. doi: 10.1093/annonc/mdz186
- Li H, Tang Y, Zhou H, Hu C, Wei L, Zhang Y, et al. Preoperative short-course radiotherapy followed by chemotherapy and PD-1 inhibitor administration for locally advanced rectal cancer: the initial results of a Randomized Phase II/III Trial (STELLAR II study). Int J Radiat Oncol Biol Phys 2024; 120: e462. doi: 10.1016/j.ijrobp.2024.07.1025
- Dijkstra EA, Nilsson PJ, Hospers GAP, Bahadoer RR, Meershoek-Klein Kranenbarg E, Roodvoets AGH, et al. Locoregional failure during and after short-course radiotherapy followed by chemotherapy and surgery compared with long-course chemoradiotherapy and surgery: a 5-year follow-up of the RAPIDO Trial. Ann Surg 2023; 278: e766-72. doi: 10.1097/SLA.0000000000005799
- Rokan Z, Simillis C, Kontovounisios C, Moran B, Tekkis P, Brown G. Locally recurrent rectal cancer according to a Standardized MRI Classification System: a systematic review of the literature. J Clin Med 2022; 11: 3511. doi: 10.3390/jcm11123511
- Bhangu A, Ali SM, Darzi A, Brown G, Tekkis P. Meta-analysis of survival based on resection margin status following surgery for recurrent rectal cancer. Colorectal Dis 2012; 14: 1457-66. doi: 10.1111/j.1463-1318.2012.03005.x
- Bhangu A, Ali M, Cunningham D, Brown G, Tekkis PP. Comparison of longterm survival outcomes of operative versus nonoperative management of recurrent rectal cancer. J Clin Oncol 2012; 30: e14132. doi: 10.1200/jco.2012.30.15_suppl.e14132
- Hagemans JAW, Van Rees JM, Alberda WJ, Rothbarth J, Nuyttens JJME, Van Meerten E, et al. Locally recurrent rectal cancer; long-term outcome of curative surgical and non-surgical treatment of 447 consecutive patients in a tertiary referral centre. Eur J Surg Oncol 2020; 46: 448-54. doi: 10.1016/j.ejso.2019.10.037
- Bird TG, Ngan SY, Chu J, Kroon R, Lynch AC, Heriot AG. Outcomes and prognostic factors of multimodality treatment for locally recurrent rectal cancer with curative intent. Int J Colorectal Dis 2018; 33: 393-401. doi: 10.1007/s00384-018-2985-y
- Zhao J. Patterns and prognosis of locally recurrent rectal cancer following multidisciplinary treatment. World J Gastroenterol 2012; 18: 7015. doi: 10.3748/wjg.v18.i47.7015
- Yamada K, Ishizawa T, Niwa K, Chuman Y, Akiba S, Aikou T. Patterns of pelvic invasion are prognostic in the treatment of locally recurrent rectal cancer. Br J Surg 2001; 88: 988-93. doi: 10.1046/j.0007-1323.2001.01811.x
- Moore HG, Shoup M, Riedel E, Minsky BD, Alektiar KM, Ercolani M, et al. Colorectal cancer pelvic recurrences: determinants of resectability. dis colon rectum 2004; 47: 1599-606. doi: 10.1007/s10350-004-0677-x
- Gao Z, Gu J. Surgical treatment of locally recurrent rectal cancer: a narrative review. Ann Transl Med 2021; 9: 1026. doi: 10.21037/atm-21-2298
- Fahy MR, Hayes C, Kelly ME, Winter DC. Updated systematic review of the approach to pelvic exenteration for locally advanced primary rectal cancer. Eur J Surg Oncol 2022; 48: 2284-91. doi: 10.1016/j.ejso.2021.12.471
- Platt E, Dovell G, Smolarek S. Systematic review of outcomes following pelvic exenteration for the treatment of primary and recurrent locally advanced rectal cancer. Tech Coloproctol 2018; 22: 835-45. doi: 10.1007/s10151-018-1883-1
- Beyond TME Collaborative; Ali SM, Antoniou A, Beynon J, Bhangu A, Bose P, et al. Consensus statement on the multidisciplinary management of patients with recurrent and primary rectal cancer beyond total mesorectal excision planes. Br J Surg 2013; 100: 1009-14. doi: 10.1002/bjs.9192
- Glynne-Jones R, Wyrwicz L, Tiret E, Brown G, Rödel C, Cervantes A, et al. Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2017; 28: iv22-40. doi: 10.1093/annonc/mdx224
- Piqeur F, Creemers DMJ, Banken E, Coolen L, Tanis PJ, Maas M, et al. Dutch national guidelines for locally recurrent rectal cancer. Cancer Treat Rev 2024; 127: 102736. doi: 10.1016/j.ctrv.2024.102736
- Enríquez-Navascués JM. Patterns of local recurrence in rectal cancer after a multidisciplinary approach. World J Gastroenterol 2011; 17: 1674. doi: 10.3748/wjg.v17.i13.1674
- Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 2021; n71. doi: 10.1136/bmj.n71
- Habermehl D, Wagner M, Ellerbrock M, Büchler MW, Jäkel O, Debus J, et al. Reirradiation using carbon ions in patients with locally recurrent rectal cancer at HIT: first results. Ann Surg Oncol 2015; 22: 2068-74. doi: 10.1245/s10434-014-4219-z
- Moningi S, Ludmir EB, Polamraju P, Williamson T, Melkun MM, Herman JD, et al. Definitive hyperfractionated, accelerated proton reirradiation for patients with pelvic malignancies. Clin Transl Radiat Oncol 2019; 19: 59-65. doi: 10.1016/j.ctro.2019.08.004
- Shirai K, Ohno T, Saitoh J ichi, Okamoto M, Katoh H, Murata K, et al. Prospective study of isolated recurrent tumor re-irradiation with carbon-ion beams. Front Oncol 2019; 9: 181. doi: 10.3389/fonc.2019.00181
- Bird TG, Ngan SY, Chu J, Kroon R, Lynch AC, Heriot AG. Outcomes and prognostic factors of multimodality treatment for locally recurrent rectal cancer with curative intent. Int J Colorectal Dis 2018; 33: 393-401. doi: 10.1007/s00384-018-2985-y
- Tang Z, Liu L, Liu D, Wu L, Lu K, Zhou N, et al. Clinical Outcomes and Safety of Different Treatment Modes for Local Recurrence of Rectal Cancer. Cancer Manag Res 2020; 12: 12277-86. doi: 10.2147/CMAR.S278427
- Al-Haidari G, Skovlund E, Undseth C, Rekstad BL, Larsen SG, Åsli LM, et al. Re-irradiation for recurrent rectal cancer - a single-center experience. Acta Oncol 2020; 59: 534-40. doi: 10.1080/0284186X.2020.1725111
- Bosman SJ, Holman FA, Nieuwenhuijzen GAP, Martijn H, Creemers GJ, Rutten HJT. Feasibility of reirradiation in the treatment of locally recurrent rectal cancer. Br J Surg 2014; 101: 1280-9. doi: 10.1002/bjs.9569
- Cai G, Zhu J, Palmer JD, Xu Y, Hu W, Gu W, et al. CAPIRI-IMRT: a phase II study of concurrent capecitabine and irinotecan with intensity-modulated radiation therapy for the treatment of recurrent rectal cancer. Radiat Oncol 2015; 10: 57. doi: 10.1186/s13014-015-0360-5
- Chung SY, Koom WS, Keum KC, Chang JS, Shin SJ, Ahn JB, et al. Treatment outcomes of re-irradiation in locoregionally recurrent rectal cancer and clinical significance of proper patient selection. Front Oncol 2019; 9: 529. doi: 10.3389/fonc.2019.00529
- Jo S, Choi Y, Park SK, Kim JY, Kim HJ, Lee YH, et al. Efficacy of dose-escalated radiotherapy for recurrent colorectal cancer. Ann Coloproctol 2016; 32: 66. doi: 10.3393/ac.2016.32.2.66
- Kishan AU, Voog JC, Wiseman J, Cook RR, Ancukiewicz M, Lee P, et al. Standard fractionation external beam radiotherapy with and without intraoperative radiotherapy for locally recurrent rectal cancer: the role of local therapy in patients with a high competing risk of death from distant disease. Br J Radiol 2017; 90: 20170134. doi: 10.1259/bjr.20170134
- Park Y, Kim K, Park HJ, Jeong SY, Park KJ, Han SW, et al. Results of re-irradiation for pelvic recurrence in anorectal cancer patients. Br J Radiol 2019; 92: 20180794. doi: 10.1259/bjr.20180794
- Sun DS, Zhang JD, Li L, Dai Y, Yu JM, Shao ZY. Accelerated hyperfractionation field-involved re-irradiation combined with concurrent capecitabine chemotherapy for locally recurrent and irresectable rectal cancer. Br J Radiol 2012; 85: 259-64. doi: 10.1259/bjr/28173562
- Susko M, Lee J, Salama J, Thomas S, Uronis H, Hsu D, et al. The use of reirradiation in locally recurrent, non-metastatic rectal cancer. Ann Surg Oncol 2016; 23: 3609-15. doi: 10.1245/s10434-016-5250-z
- Tanaka H, Yamaguchi T, Hachiya K, Okada S, Kitahara M, Matsuyama K, et al. Radiotherapy for locally recurrent rectal cancer treated with surgery alone as the initial treatment. Radiat Oncol J 2017; 35: 71-7. doi: 10.3857/roj.2016.02005
- Tao R, Tsai CJ, Jensen G, Eng C, Kopetz S, Overman MJ, et al. Hyperfractionated accelerated reirradiation for rectal cancer: an analysis of outcomes and toxicity. Radiother Oncol 2017; 122: 146-51. doi: 10.1016/j.radonc.2016.12.015
- Watanabe J, Shoji H, Hamaguchi T, Miyamoto T, Hirano H, Iwasa S, et al. Chemoradiotherapy for local recurrence of rectal cancer: a single center study of 18 patients. In Vivo 2019; 33: 1363-8. doi: 10.21873/invivo.11612
- Youssef FF, Parikh PJ, DeWees TA, Mutch MG, Tan BR, Grigsby PW, et al. Efficacy and toxicity of rectal cancer reirradiation using IMRT for patients who have received prior pelvic radiation therapy. Adv Radiat Oncol 2016; 1: 94-100. doi: 10.1016/j.adro.2016.02.002
- Koom WS, Choi Y, Shim SJ, Cha J, Seong J, Kim NK, et al. Reirradiation to the pelvis for recurrent rectal cancer. J Surg Oncol 2012; 105: 637-42. doi: 10.1002/jso.23023
- Das P, Delclos ME, Skibber JM, Rodriguez-Bigas MA, Feig BW, Chang GJ, et al. Hyperfractionated accelerated radiotherapy for rectal cancer in patients with prior pelvic irradiation. Int J Radiat Oncol Biol Phys 2010; 77: 60-5. doi: 10.1016/j.ijrobp.2009.04.056
- Cai G, Zhu J, Hu W, Zhang Z. Accelerated hyperfractionated intensity-modulated radiotherapy for recurrent/unresectable rectal cancer in patients with previous pelvic irradiation: results of a phase II study. Radiat Oncol 2014; 9: 278. doi: 10.1186/s13014-014-0278-3
- Holman FA, Bosman SJ, Haddock MG, Gunderson LL, Kusters M, Nieuwenhuijzen GAP, et al. Results of a pooled analysis of IOERT containing multimodality treatment for locally recurrent rectal cancer. Eur J Surg Oncol 2017; 43: 107-17. doi: 10.1016/j.ejso.2016.08.015
- Dagoglu N, Mahadevan A, Nedea E, Poylin V, Nagle D. Stereotactic body radiotherapy (SBRT) reirradiation for pelvic recurrence from colorectal cancer. J Surg Oncol 2015; 111: 478-82. doi: 10.1002/jso.23858
- DeFoe S, Bernard M, Rwigema JC, Heron D, Ozhasoglu C, Burton S. Stereotactic body radiotherapy for the treatment of presacral recurrences from rectal cancers. J Can Res Ther 2011; 7: 408. doi: 10.4103/09731482.92000
- Johnstone P, Okonta L, Aitken K, Holmes J, Harrison M, Harji D, et al. A multicentre retrospective review of SABR reirradiation in rectal cancer recurrence. Radiother Oncol 2021; 162: 1-6. doi: 10.1016/j.radonc.2021.06.030
- Kim MS, Choi C, Yoo S, Cho C, Seo Y, Ji Y, et al. Stereotactic Body radiation therapy in patients with pelvic recurrence from rectal carcinoma. Jpn J Clin Oncol 2008; 38: 695-700. doi: 10.1093/jjco/hyn083
- Minneci M, Baclay JRM, Von Eyben R, Vitzthum L, Pollom E, Chang DT. The utility of stereotactic body radiotherapy for pelvic recurrences after prior radiation therapy. Int J Radiat Oncol Biol Phys 2021; 111: e59-60. doi: 10.1016/j.ijrobp.2021.07.405
- Smith T, O’Cathail SM, Silverman S, Robinson M, Tsang Y, Harrison M, et al. Stereotactic body radiation therapy reirradiation for locally recurrent rectal cancer: outcomes and toxicity. Adv Radiat Oncol 2020; 5: 1311-9. doi: 10.1016/j.adro.2020.07.017
- Yamada S, Kamada T, Ebner DK, Shinoto M, Terashima K, Isozaki Y, et al. Carbon-ion radiation therapy for pelvic recurrence of rectal cancer. Int J Radiat Oncol Biol Phys 2016; 96: 93-101. doi: 10.1016/j.ijrobp.2016.04.022
- Yamada S, Takiyama H, Isozaki Y, Shinoto M, Ebner DK, Koto M, et al. Carbon ion radiotherapy for locally recurrent rectal cancer of patients with prior pelvic irradiation. Ann Surg Oncol 2022; 29: 99-106. doi: 10.1245/s10434-021-10876-4
- Takagawa Y, Suzuki M, Seto I, Azami Y, Machida M, Takayama K, et al. Proton beam reirradiation for locally recurrent rectal cancer patients with prior pelvic irradiation. J Radiat Res 2024; 65: 379-86. doi: 10.1093/jrr/rrae019
- Takagawa Y, Suzuki M, Yamaguchi H, Seto I, Azami Y, Machida M, et al. Outcomes and prognostic factors for locally recurrent rectal cancer treated with proton beam therapy. Adv Radiat Oncol 2023; 8: 101192. doi: 10.1016/j.adro.2023.101192
- Shinoto M, Yamada S, Okamoto M, Shioyama Y, Ohno T, Nakano T, et al. Carbon-ion radiotherapy for locally recurrent rectal cancer: Japan Carbon-ion Radiation Oncology Study Group (J-CROS) Study 1404 Rectum. Radiother Oncol 2019; 132: 236-40. doi: 10.1016/j.radonc.2018.10.007
- Shiba S, Okamoto M, Shibuya K, Kobayashi D, Miyasaka Y, Ohno T. Five-year outcomes in carbon-ion radiotherapy for postoperative pelvic recurrence of rectal cancer: a prospective clinical trial (GUNMA 0801). Clin Transl Radiat Oncol 2024; 44: 100701. doi: 10.1016/j.ctro.2023.100701
- Koroulakis A, Molitoris J, Kaiser A, Hanna N, Bafford A, Jiang Y, et al. Reirradiation for rectal cancer using pencil beam scanning proton therapy: a single institutional experience. Adv Radiat Oncol 2021; 6: 100595. doi: 10.1016/j.adro.2020.10.008
- Jeans EB, Ebner DK, Takiyama H, Qualls K, Cunningham DA, Waddle MR, et al. Comparing oncologic outcomes and toxicity for combined modality therapy vs. carbon-ion radiotherapy for previously irradiated locally recurrent rectal cancer. Cancers 2023; 15: 3057. doi: 10.3390/cancers15113057
- Hiroshima Y, Ishikawa H, Murakami M, Nakamura M, Shimizu S, Enomoto T, et al. Proton beam therapy for local recurrence of rectal cancer. Anticancer Res 2021; 41: 3589-95. doi: 10.21873/anticanres.15147
- Chung SY, Takiyama H, Kang JH, Chang JS, Min BS, Tsuji H, et al. Comparison of clinical outcomes between carbon ion radiotherapy and X-ray radiotherapy for reirradiation in locoregional recurrence of rectal cancer. Sci Rep 2022; 12: 1845. doi: 10.1038/s41598-022-05809-4
- Cai X, Du Y, Wang Z, Li P, Yu Z, Zhang Q, et al. The role of carbon ion radiotherapy for unresectable locally recurrent rectal cancer: a single institutional experience. Radiat Oncol 2020; 15: 209. doi: 10.1186/s13014-020-01653-w
- Cai X, Li P, Zhao J, Wang W, Cheng J, Zhang G, et al. Definitive carbon ion re-irradiation with pencil beam scanning in the treatment of unresectable locally recurrent rectal cancer. J Radiat Res 2023; 64: 933-9. doi: 10.1093/jrr/rrad068
- Barcellini A, Vitolo V, Cobianchi L, Peloso A, Vanoli A, Mirandola A, et al. Reirradiation with carbon ion radiotherapy for pelvic rectal cancer recurrences in patients previously irradiated to the pelvis. In Vivo 2020; 34: 1547-53. doi: 10.21873/invivo.11944
- Hamauchi S, Yamazaki K, Yasui H, Boku N, Onozawa Y, Fukutomi A, et al. Safety and efficacy of proton-beam radiation therapy for patients with locally recurrent rectal cancer. Ann Oncology 2012; 23: xi160. doi: 10.1016/S0923-7534(20)32506-0
- Shiba S, Okamoto M, Kiyohara H, Ohno T, Kaminuma T, Asao T, et al. Prospective observational study of high-dose carbon-ion radiotherapy for pelvic recurrence of rectal cancer (GUNMA 0801). Front Oncol 2019; 9: 702. doi: 10.3389/fonc.2019.00702
- Shioyama Y. A phase II clinical trial of carbon-ion radiotherapy for patients with local recurrence after primarily resected rectal cancer (HIMAT1351) [Internet]. Clinical trial registration. [cited 2025 Sep 13]. Available at: https://center6.umin.ac.jp/cgi-open-bin/ctr/ctr.cgi?function=brows&action=brows&type=summary&language=J&recptno=R000015979
- Yamada S. A phase II clinical trial of carbon-ion radiotherapy for pelvic recurrent rectal cancer in patients with prior pelvic carbon-ion irradiation. [Internet]. UMIN Clinical Trials Registry U. [cited 2025 Sep 13]. Available at: https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000025839
- Cai X. A Prospective Phase II clinical study of carbon ion re-irradiation in unresectable locally recurrent rectal cancer [Internet]. [Clinical trial registration] clinicaltrials.gov; 2023 [cited 2025 Sep 13]. Available at: https://clinicaltrials.gov/study/NCT05807984
- Wan J, Wu R, Fu M, Shen L, Zhang H, Wang Y, et al. TORCH-R trial protocol: hypofractionated radiotherapy combined with chemotherapy and toripalimab for locally recurrent rectal cancer: a prospective, single-arm, two-cohort, phase II trial. Front Oncol 2023; 13: 1304767. doi: 10.3389/fonc.2023.1304767
- Kim HC. Concurrent chemo-proton radiotherapy with or without resection and spacer insertion for loco-regional recurrence of previous irradiated rectal cancer (RECCPT) [Internet]. [cited 2025 Sep 14]. Available at: https://clinicaltrials.gov/study/NCT03098108.clinicaltrials.gov; 2018.
- Washington University School of Medicine. Hypofractionated pencil-beam scanning intensity-modulated proton therapy (IMPT) in recurrent rectal cancer (IMPARC) [Internet]. [cited 2025 Sep 14]. Available at: https://clini-caltrials.gov/study/NCT04827732.2025.
- Truelsen CG, Rønde HS, Kallehauge JF, Szpejewska JE, Bahij R, Diness LV, et al. Acute toxicity and quality of life in dose-escalated proton reirradiation for locally recurrent rectal cancer: the prospective ReRad II trial. Clin Transl Radiat Oncol 2025; 54: 100999. doi: 10.1016/j.ctro.2025.100999
- Gambacorta MA, Romano A, Caravatta L, Macchia G, Chiloiro G, Galofaro E, et al. Radiotherapy & total neoadjuvant therapy for recurrent rectal cancer in previously irradiated patients, (RETRY): a multicenter prospective observational study. Radiat Oncol 2024; 19: 174. doi: 10.1186/s13014-024-02555-x
- Denost Q, Frison E, Salut C, Sitta R, Rullier A, Harji D, et al. A phase III randomized trial evaluating chemotherapy followed by pelvic reirradiation versus chemotherapy alone as preoperative treatment for locally recurrent rectal cancer – GRECCAR 15 trial protocol. Colorectal Dis 2021; 23: 1909-18. doi: 10.1111/codi.15670
- Combs SE, Kieser M, Habermehl D, Weitz J, Jäger D, Fossati P, et al. Phase I/II trial evaluating carbon ion radiotherapy for the treatment of recurrent rectal cancer: the PANDORA-01 trial. BMC Cancer 2012; 12: 137. doi: 10.1186/1471-2407-12-137
- Peterson J, Niles C, Patel A, Boujaoude Z, Abouzgheib W, Goldsmith B, et al. Stereotactic body radiotherapy for large (> 5 cm) non–small-cell lung cancer. Clin Lung Cancer 2017; 18: 396-400. doi: 10.1016/j.cllc.2016.11.020
- Dawson LA, Hashem S, Bujold A. Stereotactic body radiation therapy for hepatocellular carcinoma. Am Soc Clin Oncol Educ Book 2012; 32: 261-4. doi: 10.14694/EdBook_AM.2012.32.171
- Shiba S, Okamoto M, Shibuya K, Okazaki S, Miyasaka Y, Ohtaka T, et al. Carbon Ion radiation therapy for postoperative pelvic recurrence of rectal cancer with a large tumor infiltrating and compressing the rectum: a case report. Adv Radiat Oncol 2021; 6: 100774. doi: 10.1016/j.adro.2021.100774
- Nagata K, Takiyama H, Tashiro K, Yamadera M, Okamoto K, Kajiwara Y, et al. Multidisciplinary management of locally recurrent rectal cancer with carbon ion radiotherapy followed by prophylactic removal of the irradiated bowel: a case report. Surg Case Rep 2024; 10: 13. doi: 10.1186/s40792-024-01811-2
- Kobayashi T, Sekimoto M, Miki H, Yamamoto N, Harino T, Yagyu T, et al. Laparoscopic polyglycolic acid spacer placement for locally recurrent rectal cancer. Colorectal Dis 2024; 26: 760-5. doi: 10.1111/codi.16882
- Sasaki R, Demizu Y, Yamashita T, Komatsu S, Akasaka H, Miyawaki D, et al. First-In-human phase 1 study of a Nonwoven Fabric Bioabsorbable Spacer for Particle Therapy: Space-Making Particle Therapy (SMPT). Adv Radiat Oncol 2019; 4: 729-37. doi: 10.1016/j.adro.2019.05.002
- Trifiletti DM, Garda AE, Showalter TN. Implanted spacer approaches for pelvic radiation therapy. Expert Rev Med Devices 2016; 13: 633-40. doi: 10.1080/17434440.2016.1195682
Language: English
Page range: 323 - 331
Submitted on: Nov 25, 2025
Accepted on: May 22, 2026
Published on: Sep 7, 2026
Published by: Association of Radiology and Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
Related subjects:
© 2026 Ana Perpar, Petra Georg, Ajra Secerov Ermenc, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons Attribution 4.0 License.